Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Journal of Clinical Immunology
|
October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Journal of Clinical Immunology
|
November 27, 2021
Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Ebiomedicine
|
April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
Barnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
JAMA
|
March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Frontiers in Immunology
|
September 29, 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity <i>via</i> spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity
Mai Chan Lau, Yang Yi, Denise Goh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Barnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine
|
March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
The Lancet. Infectious Diseases
|
October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial
David L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
Ruklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Journal of Clinical Immunology
|
October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Journal of Clinical Immunology
|
November 27, 2021
Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Ebiomedicine
|
April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
Barnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
EMBO Molecular Medicine
|
May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
JAMA
|
March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Frontiers in Immunology
|
September 29, 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity <i>via</i> spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity
Mai Chan Lau, Yang Yi, Denise Goh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Barnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine
|
March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
The Lancet. Infectious Diseases
|
October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial
David L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
Ruklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
Page
of 10